Please login to the form below

Not currently logged in

S-A invests €350m in vaccine facility

Leading vaccine manufacturer sanofi-aventis is to construct a new manufacturing centre in Neuville-sur-Saône, France

Leading vaccine manufacturer sanofi-aventis is to construct a new manufacturing centre in Neuville-sur-Saône, France.

The new centre, near to Lyon, will come under the remit of the group's vaccine division, Sanofi Pasteur and employ 200 people. The facility will produce 100 million doses of the novel dengue fever vaccine, which is currently under development, and expects to be operational by 2013.

"This new vaccine production centre is the largest investment ever made by sanofi-aventis. It illustrates our commitment to providing solutions to unmet medical needs such as dengue, a disease that potentially puts almost half of the world's population at risk," said Christopher A Viehbacher, CEO of sanofi-aventis.

He went on to say that, including this latest investment, sanofi-aventis has invested over €1bn in vaccine production in France since 2005.

The French company is keen to respond to increasing global health needs through innovation. Earlier this month, sanofi-aventis announced it has invested almost €200m to convert its pharmaceutical production site at Vitry-sur-Seine in France to produce monoclonal antibodies.

13th May 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...